Management tracks: Gottlieb joins FasterCures’ board; plus Foghorn, Varian
Former FDA Commissioner Scott Gottlieb has been appointed to the advisory board of FasterCures, a center of the Milken Institute dedicated to speeding up and improving medical research. Gottlieb stepped down from FDA's top post in April.
Chromatin remodeling company Foghorn Therapeutics Inc. (Cambridge, Mass.) hired Samuel Agresta as its first CMO and Allan Reine as its first CFO. Agresta was CMO at Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and was previously VP and head of clinical development at Agios Pharmaceuticals Inc. (NASDAQ:AGIO). Reine was CFO at Pieris Pharmaceuticals Inc. (NASDAQ:PIRS). Flagship Pioneering's Flagship VentureLabs launched Foghorn last year with a $50 million capital commitment (see "Foghorn Launches with $50M for Chromatin Remodeling Platform")...